PTCH1 and skin basal cell carcinoma: In contrast to his liver metastasis, the in situ carcinoma had a somewhat lower tumor mutational burden, lacked PD-L1/2 amplification, and had a distinct PTCH1 mutation, suggesting that the in situ BCC of his skin and the metastatic BCC of his liver were derived from different clones of cells.